National Cancer Institute opens first therapeutic vaccine trial for chordoma patients
The National Cancer Institute has expanded an ongoing Phase I clinical trial of a therapeutic vaccine targeting the brachyury protein … Continue reading
The National Cancer Institute has expanded an ongoing Phase I clinical trial of a therapeutic vaccine targeting the brachyury protein … Continue reading
Following the Fourth International Chordoma Research Workshop, letters of intent poured in with new ideas and potential collaborations that researchers … Continue reading
Last month, doctors, scientists, patients, and family members from around the world gathered in Boston for the Fourth International Chordoma … Continue reading
Whether a patient, family member, volunteer, donor, physician, or researcher, our connection to chordoma makes us uncommon in what we make of … Continue reading
Dr. Tom DeLaney of Massachusetts General Hospital is leading a new Phase II study that will utilize the newest technology … Continue reading
Over the past several years, interest in chordoma has grown and numerous new investigators have ventured into chordoma research. During … Continue reading
Father sets course for his family with transformational gift and commitment to the Chordoma Foundation Kim Song Young-dahl Song The … Continue reading
Chordoma Foundation Executive Director, Josh Sommer, has been named by Forbes to its list of “30 Under 30,” 30 individuals … Continue reading
The University of Pittsburgh and Dignity Health’s Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center are the latest … Continue reading
In the year following the Third International Chordoma Research Workshop, participants formed 30 new collaborations (thick lines) and 174 new … Continue reading